Novartis Home
At Novartis, we are reimagining medicine
At Novartis, we are reimagining medicine
Behind the research driving our data
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
A decades-long journey in blood cancer research
Novartis immunologist describes the excitement of discovering a promising new immuno-oncology target in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome.
Accelerating our digital transformation with Amazon Web Services (AWS)
We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.
Latest News
Novartis on Twitter
New cell and gene facility inaugurated in Switzerland
Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.